Answers are grounded in this paper and cite their sources.
Upper limb motor impairment is among the most common and most persistent consequences of stroke.Robotic exoskeletons may deliver the high-intensity, repetitive, task-specific practice that drives motor recovery, but their efficacy as a distinct device class remains undetermined, since previous syntheses pooled them with end-effector devices.We searched PubMed, Scopus, Web of Science, the Cochrane Library, and Embase from inception until July 3, 2026, for randomized controlled trials comparing upper limb exoskeleton training with conventional therapist-mediated therapy in adults with stroke.We included 11 trials randomizing 371 patients and analyzing 338.Exoskeleton training produced greater improvement in total Fugl-Meyer Assessment for Upper Extremity (FMA-UE) score (mean difference 2.45, 95% CI 0.88 to 4.01, p = 0.002).Subgroup analysis by stroke phase showed a significant difference between strata (p = 0.011), with a large effect in subacute stroke (mean difference 5.31, 95% CI 2.73 to 7.89, p < 0.0001) and no significant effect in chronic stroke (mean difference 1.46, 95% CI 0.00 to 2.93, p = 0.05).Exoskeleton training also improved the proximal FMA-UE subscore (p < 0.0001), the Action Research Arm Test (p = 0.0003), and the distal FMA-UE subscore (p = 0.02), but did not affect spasticity measured by the Modified Ashworth Scale.Robotic exoskeleton training confers a statistically significant but modest advantage for upper limb motor impairment after stroke.The benefit is concentrated in the subacute phase and is greater proximally than distally, supporting its use.
No takes yet. Share an insight, caveat, or question.
Sager et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: